Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

May 13, 2025

Renamed

N-Methyl-N-ethyltryptamine renamed to Methylethyltryptamine.

Reassessed

Fentanyl (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)
PNU-22394 (talk) reassessed. Importance rating changed from Unknown-Class to Low-Class. (rev · t)

Assessed

Methylethyltryptamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
SPT-348 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

May 12, 2025

Assessed

BQCA (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

May 11, 2025

Assessed

Acelyrin (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
BAY 2413555 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

May 10, 2025

Renamed

Redsenol renamed to Redsenol.

Reassessed

Nicotine pouch (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
Ralfinamide (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

VU6028418 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
VU6036864 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

May 9, 2025

Assessed

AZD9164 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
PIPE-359 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

Removed

File:Ibuprofen hepatic metabolism.png (talk) removed.

May 8, 2025

Reassessed

Magid Abou-Gharbia (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Pipequaline (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Ramatroban (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Tipepidine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

Nelremagpran (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
PSB-22040 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

May 7, 2025

Reassessed

BOM (drug) (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
BOx (psychedelics) (talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. (rev · t)
CE-LAD (talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. (rev · t)
DEMPDHPCA (talk) reassessed. Quality rating changed from Unassessed-Class to B-Class. (rev · t)
Dibenzodiazepine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Ethylpropyllysergamide (talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. (rev · t)

Assessed

CIA Drug Trafficking (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:CIA drug trafficking allegations (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
CIA involvement in Contra cocaine trafficking (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Draft:Erythrocyte membrane-coated nanoparticles (talk) assessed. Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Argentina (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Austria (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Belarus (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Belgium (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Bosnia and Herzegovina (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Brazil (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Canada (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Chile (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Croatia (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Cyprus (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of England (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Ghana (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Greece (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Hong Kong (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Hungary (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Iceland (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Italy (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Nigeria (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Poland (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Romania (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Spain (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Sri Lanka (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Tunisia (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of Ukraine (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of the Czech Republic (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of the Philippines (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical companies of the United Arab Emirates (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Category:Pharmaceutical company founders (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)